中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

475 records (took 0.025 seconds)

    SULFONAMIDE AND ITS USE
    1.
    发明专利
    SULFONAMIDE AND ITS USE 失效

    公开(公告)号：JPH1067734A

    公开(公告)日：1998-03-10

    申请号：JP16706097

    申请日：1997-06-24

    Applicant: HOFFMANN LA ROCHE

    Inventor： BOES MICHAEL ,  GODEL THIERRY ,  RIEMER CLAUS ,  SLEIGHT ANDREW

    IPC: A61K31/63 ,  A61K31/18 ,  A61K31/325 ,  A61K31/40 ,  A61K31/403 ,  A61K31/404 ,  A61K31/44 ,  A61K31/505 ,  A61P25/00 ,  C07C311/21 ,  C07C311/38 ,  C07C311/44 ,  C07D209/08 ,  C07D213/76 ,  C07D239/48 ,  C07D239/50 ,  C07D239/69 ,  C07D403/04

    Abstract: PROBLEM TO BE SOLVED: To obtain a medicine containing one of specific sulfonamide compounds partially including new compounds as an active ingredient, having good affinity for 5HT-6 receptors and useful for treating central nerve diseases such as psychosis, schizophrenia, manic depressive psychosis and depression. SOLUTION: This medicine contains a compound of formula I [R is H, amino, an alkylamino, an alkyl, etc.; R is H, an alkyl; Z is a group of formula II (R is H, amino, CF3 , an alkyl, etc.; R is amino, an alkyl, an alkoxy, etc.), a group of formula III (R is H, a halogen, an alkoxy, etc.; R is an alkyl, an alkylamino, an alkoxy, CF3 , etc.), etc.] or its pharmaceutically permissible salt. E.g. a compound (salt) of formula IV (R is H, an alkoxy, etc.; R is amino, an alkylamino), a compound (salt) of formula V (R is H, an alkylamino, etc.; R is an alkyl, CF3 , etc.), etc., are new among the compound of formula I. The compound of formula I is suitable for the treatments of dysmnesia, Parkinson's disease, amyotrophic lateral aclerosis, Alzheimer's disease and Huntington's disease.

    PHENYL- AND PYRIDINYL DERIVATIVES AS NEUROKININ 1 ANTAGONISTS
    3.
    发明申请
    PHENYL- AND PYRIDINYL DERIVATIVES AS NEUROKININ 1 ANTAGONISTS 审中-公开
    苯并吡啶衍生物作为神经营养因子1拮抗剂

    公开(公告)号：WO0050398A3

    公开(公告)日：2001-04-05

    申请号：PCT/EP0001224

    申请日：2000-02-15

    Applicant: HOFFMANN LA ROCHE

    Inventor： BOES MICHAEL ,  GALLEY GUIDO ,  GODEL THIERRY ,  HOFFMANN TORSTEN ,  HUNKELER WALTER ,  SCHNIDER PATRICK ,  STADLER HEINZ

    IPC: C07C211/44 ,  A61K31/167 ,  A61K31/44 ,  A61P25/00 ,  A61P29/00 ,  C07C211/54 ,  C07C233/29 ,  C07C233/33 ,  C07C233/44 ,  C07C317/14 ,  C07C317/40 ,  C07C323/41 ,  C07D213/75 ,  C07D213/79 ,  C07D213/81 ,  C07D295/12 ,  C07D295/135 ,  C07D401/04

    CPC classification number: C07D213/75 ,  C07C233/29 ,  C07C233/33 ,  C07C233/44 ,  C07C317/40 ,  C07C323/41 ,  C07D295/135

    Abstract: The invention relates to compounds of general formula (I), wherein R is hydrogen, lower alkyl, lower alkoxy, halogen or trifluoromethyl; R is hydrogen or halogen; or R and R may be together -CH=CH-CH=CH-; R is hydrogen, halogen, trifluoromethyl, lower alkoxy or cyano; R is independently from each other hydrogen, lower alkyl or form a cycloalkyl group; R is hydrogen, halogen, lower alkyl, lower alkoxy, -N(R )2, -N(R )S(O)2-lower alkyl, -N(R )C(O)R or a cyclic tertiary amine of the group (a); R is, independently from each other, hydrogen, C3-6-cycloalkyl, benzyl or lower alkyl; R is hydrogen, hydroxy, lower alkyl, -N(R )CO-lower alkyl, hydroxy-lower alkyl, cyano, -CHO or a 5- or 6 membered heterocyclic group, optionally bonded via an alkylene group, X is -C(O)N(R )-, -(CH2)mO-, -(CH2)mN(R )-, -N(R ) C(O)-, C(O)O- or -N(R )(CH2)m-; Y is -(CH2)n-, -O-, -S-, SO2-, -C(O)- or -N(R )-; Z is =N-, -CH= or -C(C1)=; n is 0 - 4; and, is 1 or 2; and to pharmaceutically acceptable acid addition salts thereof. It has been shown that the compounds of formula (I) have a high affinity to the NK-1 receptor.

    Abstract translation: 本发明涉及通式（I）的化合物，其中R是氢，低级烷基，低级烷氧基，卤素或三氟甲基; R 1是氢或卤素; 或R和R 1可以一起是-CH = CH-CH = CH-; R 2是氢，卤素，三氟甲基，低级烷氧基或氰基; R 3彼此独立地为氢，低级烷基或形成环烷基; R 4是氢，卤素，低级烷基，低级烷氧基，-N（R 5）2，-N（R 5）S（O）2-低级烷基，-N（R 5） C（O）R 5或（a）组的环状叔胺; R 5彼此独立地为氢，C 3-6 - 环烷基，苄基或低级烷基; R 6是氢，羟基，低级烷基，-N（R 5）CO-低级烷基，羟基 - 低级烷基，氰基，-CHO或5-或6-元杂环基，任选经由亚烷基键合 ，X是-C（O）N（R 5） - ， - （CH 2）m O - ， - （CH 2）m N（R 5） - ， - N（R 5）C（O） ，C（O）O-或-N（R 5）（CH 2）m - ; Y是 - （CH 2）n - ， - O - ， - S - ，SO 2 - ， - C（O） - 或-N（R 5） Z是= N-，-CH =或-C（C1）=; n为0-4; 是1或2; 及其药学上可接受的酸加成盐。 已经表明式（I）化合物对NK-1受体具有高亲和力。

    5-PHENYL-PYRIMIDINE DERIVATIVES
    4.
    发明申请
    5-PHENYL-PYRIMIDINE DERIVATIVES 审中-公开
    5-苯基 - 吡啶衍生物

    公开(公告)号：WO0073278A2

    公开(公告)日：2000-12-07

    申请号：PCT/EP0004702

    申请日：2000-05-24

    Applicant: HOFFMANN LA ROCHE

    Inventor： BOES MICHAEL ,  GALLEY GUIDO ,  GODEL THIERRY ,  HOFFMANN TORSTEN ,  HUNKELER WALTER ,  SCHNIDER PATRICK ,  STADLER HEINZ

    IPC: A61K31/505 ,  A61K31/506 ,  A61K31/513 ,  A61K31/5377 ,  A61P1/04 ,  A61P1/08 ,  A61P9/00 ,  A61P11/02 ,  A61P11/06 ,  A61P17/02 ,  A61P25/00 ,  A61P25/06 ,  A61P25/16 ,  A61P25/22 ,  A61P25/24 ,  A61P25/28 ,  A61P25/30 ,  A61P29/00 ,  A61P37/08 ,  A61P43/00 ,  C07D213/00 ,  C07D239/00 ,  C07D239/28 ,  C07D239/34 ,  C07D239/38 ,  C07D239/42 ,  C07D239/46 ,  C07D239/48 ,  C07D295/00 ,  C07D401/04

    CPC classification number: C07D239/28 ,  C07D239/34 ,  C07D239/42 ,  C07D239/47 ,  C07D239/48

    Abstract: The invention relates to compounds of general formula (I) wherein R is hydrogen or halogen; R is hydrogen, halogen, lower alkyl or lower alkoxy; R is halogen, trifluoromethyl, lower alkoxy or lower alkyl; R /R are independently from each other hydrogen or lower alkyl; R is lower alkyl, lower alkoxy, amino, hydroxy, hydroxy-lower alkyl, -(CH2)n-piperazinyl, optionally substituted by lower alkyl, -(CH2)n-morpholinyl, -(CH2)n+1-imidazolyl, -O-(CH2)n+1-morpholinyl, -O-(CH2)n+1-piperidinyl, lower alkyl-sulfanyl, lower alkyl-sulfonyl, benzylamino, -NH-(CH2)n+1N(R )2, -(CH2)n-NH-(CH2)n+1N(R )2, -(CH2)n+1N(R )2, or -O-(CH2)n+1N(R )2, wherein R is hydrogen or lower alkyl; R is hydrogen; R and R or R and R may be together with the two carbon ring atoms -CH=CH-CH=CH-, with the proviso that n for R is 1; n is independently 0 - 2; and X is -C(O)N(R )- or -N(R )C(O)-; and pharmaceutically acceptable acid addition salts thereof. Compounds of formula (I) have a high affinity to the NK-1 receptor. They are therefore useful for the treatment or diseases which relate to this receptor.

    Abstract translation: 本发明涉及通式（I）的化合物，其中R 1是氢或卤素; R 2是氢，卤素，低级烷基或低级烷氧基; R 3是卤素，三氟甲基，低级烷氧基或低级烷基; R 4 / R 4彼此独立地为氢或低级烷基; - （CH 2）n - 吗啉基， - （CH 2）n + 1-烷基， - （CH 2）n - 咪唑基，-O-（CH 2）n + 1-吗啉基，-O-（CH 2）n + 1-哌啶基，低级烷基 - 硫烷基，低级烷基 - 磺酰基，苄基氨基，-NH-（CH 2）n + 4“>）2， - （CH 2）n -NH-（CH 2）n + 1N（R 4”）2， - （CH 2）n + 1N（R 4“）2或-O- CH 2）n + 1N（R 4“）2，其中R 4是氢或低级烷基; R 6是氢; R 2和R 6或R 1和R” 6>可以与两个碳环原子-CH = CH-CH = CH-一起，条件是R 1的n为1; n独立地为0-2;且X为-C（O）N （R 4） - 或-N（R 4）C（O） - 及其药学上可接受的酸加成盐。式（I）化合物对NK-1受体具有高亲和力 因此可用于与该受体相关的治疗或疾病。

    ISOQUINOLINE DERIVATIVES FOR USE AGAINST CNS DISORDERS
    5.
    发明申请
    ISOQUINOLINE DERIVATIVES FOR USE AGAINST CNS DISORDERS 审中-公开
    用于中枢神经系统疾病的异喹啉衍生物

    公开(公告)号：WO9924022A2

    公开(公告)日：1999-05-20

    申请号：PCT/EP9806920

    申请日：1998-11-02

    Applicant: HOFFMANN LA ROCHE

    Inventor： GODEL THIERRY ,  HUNKELER WALTER

    IPC: A61K31/472 ,  A61K31/4725 ,  A61K31/4741 ,  A61K31/00

    CPC classification number: A61K31/472 ,  A61K31/4725 ,  A61K31/4741

    Abstract: The invention relates to the use of isoquinoline derivatives of general formula (I) wherein R , R and R are hydrogen, halogen, lower alkyl, lower alkoxy or R and R taken together form a methylenedioxy group, Z is (a), (b), (c) or (d); R is CF3, halogen, lower alkoxy, lower alkyl or lower alkyl-halogen; p is 1-3; n is 0-5 and of their pharmaceutically acceptable salts in the treatment of disorders which are associated with 5HT7 receptors.

    Abstract translation: 本发明涉及通式（I）的异喹啉衍生物，其中R 1，R 2和R 3为氢，卤素，低级烷基，低级烷氧基或R 2和R 3为氢， 一起形成亚甲二氧基，Z是（a），（b），（c）或（d）; R为CF 3，卤素，低级烷氧基，低级烷基或低级烷基 - 卤素; p为1-3; n为0-5及其药学上可接受的盐，用于治疗与5HT7受体相关的病症。

Patent Agency Ranking